Key result
Catheter ablation combined with left atrial appendage occlusion for non-valvular atrial fibrillation demonstrated a pooled follow-up embolism event rate of 1.29% and an all-cause mortality rate of 0.32%.
Why the study?
To estimate the effect of catheter ablation combined with left appendage occlusion in the treatment of non-valvular atrial fibrillation.
Does catheter ablation combined with left appendage occlusion provide a safe and effective treatment for patients with non-valvular atrial fibrillation?
Meta-Analysis (n=1,385)
Does catheter ablation combined with left appendage occlusion provide a safe and effective treatment for patients with non-valvular atrial fibrillation?
The combined 'one-stop' procedure of catheter ablation and LAAO appears effective for NVAF, with low rates of mortality and embolism, though NVAF recurrence remains around 29%.
Answers are grounded in this paper and cite their sources.
Supports combined ablation-LAAO feasibility with low embolic risk; leaves open randomized trials versus standard care.
OBJECTIVE: To estimate the effect of catheter ablation combined with left appendage occlusion in the treatment of non-valvular atrial fibrillation (NVAF) by a method of meta-analysis. METHODS: Pubmed, Embase, and Cochrane Library were searched for the studies about catheter ablation combined with left appendage occlusion in treating NVAF. The data analysis was performed using R 4.0.5 software. The retrieval time was from inception to May 12, 2021. RESULTS: A total of 18 published studies were identified in the meta-analysis, including 1385 participants. During the perioperative period of catheter ablation combined with left appendage occlusion in treating NVAF, the pooled incidences of pericardial effusion, major or minor bleeding events, and residual flow documented were 0.5%(95%CI 0.0002-0.0099), 1.42%(95% CI 0.00-0.04), 7.24%(95% CI 0.0447-0.0975), respectively. During the follow-up, the incidences of all-cause mortality, embolism events, and bleeding events were 0.32%(95%CI 0.0000-0.0071), 1.29%(95%CI 0.0037-0.0222), 2.07%(95% CI 0.0075-0.0339), respectively. In the follow-up period of the transesophageal echocardiography, the most complication was residual flow event with an incident rate of 10.80%(95% CI 0.054-0.1620). The maximum occurrence probability of residual flow events was 17.92% (95% CI 0.1133-0.2452). Moreover, the incident rate of NVAF recurrence was 29.23% (95% CI 0.2222-0.3623). CONCLUSION: The meta-analysis suggests that the "one-stop" procedure is effective for those patients undergoing NVAF. However, Patients with more residual blood flow have a higher incidence of bleeding complications. More studies are warranted to verify the safety and efficacy of catheter ablation combined with left appendage occlusion in terms of the "one-stop" procedure.
No takes yet. Share an insight, caveat, or question.
Qu et al. (2022) conducted a meta-analysis in Non-valvular atrial fibrillation (NVAF) (n=1,385). Catheter ablation combined with left atrial appendage occlusion was evaluated on Embolism events during follow-up (1.29%, 95% CI 0.0037-0.0222). Catheter ablation combined with left atrial appendage occlusion for non-valvular atrial fibrillation demonstrated a pooled follow-up embolism event rate of 1.29% and an all-cause mortality rate of 0.32%.
Synapse has enriched 10 related papers. Consider them for comparative context: